Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease
Maryland-based biotechnology leader, Elixirgen Scientific, Inc., launches Alzheimer’s Disease Panel, strengthening their commitment to quality and innovation in disease research and drug discovery. Elixirgen Scientific,...
Rancho Biosciences Joins Forces With Davos Alzheimer’s Collaborative in Global Fight Against Alzheimer’s Disease
Rancho Biosciences, a data Science Services company known for its data curation and harmonization capabilities, is excited to announce its work with the Davos Alzheimer's...
Core One’s Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease
VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the "Company" or "Core One"), is excited to share positive...
Alliance for Aging Research Celebrates the First-Ever, FDA Traditional Approval of a Disease-Modifying Therapy for Early Alzheimer’s
Calls on CMS to Stop Rationing Care and Immediately Retire Its Excessively Restrictive "Coverage with Evidence Development" Medicare PolicyWASHINGTON, D.C. / ACCESSWIRE / July 6,...
Photobiomodulation Treatments Are Demonstrating Neuroinflammation Reduction Potential
A recently published study from Stanford University [see link] demonstrated the potential benefits of photobiomodulation (PBM) in a mouse model of neuroinflammation. Neuroinflammation is a key...
BrainCheck Appoints Kim Rodriguez as CEO
Rodriguez brings healthcare leadership experience to fast-growing, digital cognitive assessment platform used by thousands of physicians and providers BrainCheck, creator of a digital cognitive assessment and...
Raleigh Company Jigsawdio Receives NIH Grant for Audiovisual Jigsaw Puzzle Device
Grant supports development and use study for puzzle created for the Alzheimer's and dementia populations. Jigsawdio, a woman-owned small business headquartered in Raleigh, N.C.,received a...
Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases
VANCOUVER, BC / ACCESSWIRE / January 24, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), in follow-up to its press...